XML 28 R17.htm IDEA: XBRL DOCUMENT

Stockholders’ Equity	9 Months Ended
Stockholders’ Equity	Sep. 30, 2020
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Shareholders’ Equity Common Stock Repurchases On May 6, 2020, Kemper’s Board of Directors authorized the repurchase of an additional $200.0 million of Kemper’s common stock, in addition to $133.3 million remaining under the August 6, 2014 authorization, bringing the remaining share repurchase authorization to approximately $333.3 million. As of September 30, 2020, the remaining share repurchase authorization was $333.3 million under the repurchase program. During the nine months ended September 30, 2020, Kemper repurchased and retired 1.6 million shares of its common stock in open market transactions under its share repurchase authorization for an aggregate cost of $110.4 million and average cost per share of $68.29. During the three months ended September 30, 2020, Kemper did not repurchase or retire any shares of its common stock under its share repurchase authorization. Common Stock Issuance On June 7, 2019, the Company completed a public offering of its common stock and issued 1.6 million shares of common stock, at $83.00 per share. Gross proceeds from the offering were $128.9 million. Transaction costs, including the underwriting discount, were $1.7 million, of which $0.3 million was accrued for and included in Accrued Expenses and Other Liabilities on the Company’s Condensed Consolidated Balance Sheet at June 30, 2019. Employee Stock Purchase Plan During the second quarter of 2019, Kemper’s stockholders approved the adoption of the Kemper Employee Stock Purchase Plan (“ESPP”) and the reservation of 1.3 million shares of Kemper’s common stock for issuance under the ESPP. Under the ESPP, the Company issued 17,720 shares on September 30, 2020 at a discounted price of $56.81 per share, 13,291 shares on June 30, 2020 at a discounted price of $61.64 per share, and 13,214 shares on March 31, 2020 at a discounted price of $63.21. Compensation costs charged against income were $0.5 million and $0.2 million for the nine and three months ended September 30, 2020, respectively. Note 9 - Shareholders’ Equity (continued) The Company issued 12,638 shares under the plan on September 30, 2019 at a discounted price of $66.26 per share. Compensation costs charged against income was $0.1 million for the three months ended September 30, 2019. There was no tax benefit recognized by the Company in relation to the ESPP for the three months ended September 30, 2019.